Brown's syndrome is characterised by limitation of elevation of the adducted eye. This disorder has been described in association with a number of connective tissue disorders including rheumatoid arthritis,' juvenile chronic arthritis,2 and systemic lupus erythematosus.3 We report here the case of a patient with primary Sjogren's syndrome who developed unilateral Brown's syndrome. To our knowledge this association has not been described previously.
Case report A 21-year-old woman presented with a 1 day history of an acute onset of diplopia noted when she looked upwards. She had been diagnosed as having primary Sjorgren's syndrome 1 year before this presentation, based on objective evidence ofdry eyes and mouth, bilateral parotid swelling, and antibodies to Ro and La antigens. Current medication was chloroquine 250 mg orally on alternate days which she had been taking for 1 year. For her dry eye symptoms she was using artificial tears (four to six times a day).
At presentation general and neurological examinations were normal. Her visual acuity was 6/5 (aided) in both eyes. Examination of eye movements revealed heterotropia in the primary position without diplopia. There was no sign of an abnormal head posture. On attempted dextroelevation of the eyes she complained of diplopia. Computed tomography of the orbits and cranial contents did not reveal any abnormality. Acquired Brown's syndrome was diagnosed. She was initially treated with oral prednisolone 60 mg daily and this was gradually tapered off to 10 mg daily over 6 weeks. Chloroquine was discontinued. She was commenced on oral azathioprine 50 mg daily as the dosage of prednisolone was lowered. ESR and C-reactive protein levels returned to her normal levels on commencement of the above treatment. Two months after presentation, the diplopia and ocular motility abnormality has decreased since her initial presentation (Fig 2) . The 
